PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

Looks like a company called Biopharm Australia own Cartrophen...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 871 Posts.
    lightbulb Created with Sketch. 216
    Looks like a company called Biopharm Australia own Cartrophen and sells worldwide via different distributors. I assume their form of iPPS is not the exact same molecule that Bene have?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $68.29M
Open High Low Value Volume
19.5¢ 20.5¢ 19.0¢ $156.2K 795.1K

Buyers (Bids)

No. Vol. Price($)
7 152244 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 25584 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.